Cora Health Tirzepatide Review: Cost, Two Named Pharmacies & Honest Verdict (2026)

Cora Health: it names two 503A compounding pharmacy partners directly on the site — Hallandale Pharmacy and VialsRx — alongside a checkable LegitScript seal ID, 49690100, in the footer. Every fact here comes from the company's own published program.

What Cora Health is

Cora Health is a direct-to-consumer telehealth platform, offering compounded semaglutide and tirzepatide with flat per-tier pricing — no surcharge as your dose escalates within a tier. It serves all 50 states, with an online intake reviewed by a licensed clinician.

What Cora Health costs

$225/month for tirzepatide, dropping to $135/month on an annual commitment — both figures present on the site. Semaglutide runs a parallel structure at $99-$175/month depending on commitment length. The lowest advertised prices require a 12-month commitment with no partial refunds, so confirm which tier applies to your quote.

Two named 503A pharmacies

This is Cora Health's strongest, most independently checkable claim: Hallandale Pharmacy and VialsRx are both named directly on the site as 503A compounding partners. Hallandale Pharmacy is PCAB-accredited and has been operating since 2003 — independently verifiable history, a real positive.

A young operating entity

Worth knowing: the operating entity behind Cora Health, Leanio Health LLC, has essentially no independent operating-history footprint — no BBB record, no press coverage, likely less than 12 months old. That doesn't contradict the pharmacy partnerships, which are independently checkable regardless of the parent company's age, but it's a distinct fact worth separating from the pharmacy credentials.

The brand-vs-compounded question

Cora Health dispenses compounded tirzepatide only — no brand-name Wegovy, Zepbound, or oral GLP-1 (orforglipron/Rybelsus) options. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Cora Health's real strengths: two named, independently checkable 503A pharmacy partners, a verified LegitScript seal ID, and flat per-tier pricing with no dose-escalation surcharge. The trade-offs: the lowest prices require a 12-month commitment with no partial refunds, the operating entity is very young with no independent track record, and there's no brand-name or oral option, with founder names and funding undisclosed. As with any GLP-1 program, and especially one behind a young operating entity, confirm your commitment tier and refund terms before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Cora Health's two named, independently checkable 503A pharmacies are a genuine transparency strength, but the operating entity behind it is very young with no independent track record — worth weighing separately from the pharmacy credentials. If a longer-established parent company matters more to you, compare it against Blue Sky MD, operating since 2008. See our best tirzepatide providers ranking for the full field.